FDA approves radical treatment for knee arthritis to ‘freeze’ cells and ease chronic pain

June 13th, 2017
shutterstock 343802927

The FDA has given the green light to a new treatment that will ease the pain of knee arthritis for people who can’t have surgery.

Newly approved ‘Coolief’ is a non-invasive procedure that uses radio frequency to freeze nerve cells to stop them from transmitting pain signals to the brain.

Although it doesn’t cure osteoarthritis, it offers an alternative treatment to patients who can’t have a knee replacement surgery.

The new technique can alleviate the debilitating pain for up to a year, an improvement from steroid injections which normally last up to 12 weeks.

The FDA’s approval comes after a study in February 2016 ¬†found that 74 percent of patients who had the treatment said their symptoms were at least reduced by half at six months.

At the 12-month mark, 65 percent said their pain was still reduced by half.

Please click the link below to read further: